Eugene T. Grygielko

Inhibition of Transforming Growth Factor (TGF)-β1–Induced Extracellular Matrix with a Novel Inhibitor of the TGF-β Type I Receptor Kinase Activity: SB-431542

Nicholas J. Laping, Eugene T. Grygielko, Anil Mathur et al. · Molecular Pharmacology · 2002 · 650 citations

Life Sciences, Molecular Biology, Pharmacology +16

Oral administration of GW788388, an inhibitor of TGF-β type I and II receptor kinases, decreases renal fibrosis

Maj Petersen, Midory Thorikay, Martijn Deckers et al. · Kidney International · 2007 · 214 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Inhibition of Gene Markers of Fibrosis with a Novel Inhibitor of Transforming Growth Factor-β Type I Receptor Kinase in Puromycin-Induced Nephritis

Eugene T. Grygielko, W. Martin, Christopher Tweed et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 189 citations

Life Sciences, Medicinal Chemistry, Pharmacology +15

Novel Rho Kinase Inhibitors with Anti-inflammatory and Vasodilatory Activities

Chris P. Doe, Ross Bentley, David J. Behm et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 156 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

Human-induced pluripotent stem cell-derived cardiomyocytes exhibit temporal changes in phenotype

Christine Y. Ivashchenko, G. C. Teg Pipes, Irina M. Lozinskaya et al. · American Journal of Physiology-Heart and Circulatory Physiology · 2013 · 151 citations

Life Sciences, Cardiology, Cell Biology +15